Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Dow
Fuji
UBS
Argus Health
Mallinckrodt
Accenture
Fish and Richardson
Farmers Insurance

Generated: December 19, 2018

DrugPatentWatch Database Preview

Lantheus Medcl Company Profile

« Back to Dashboard

What is the competitive landscape for LANTHEUS MEDCL, and what generic alternatives to LANTHEUS MEDCL drugs are available?

LANTHEUS MEDCL has nine approved drugs.

There are five US patents protecting LANTHEUS MEDCL drugs.

There are eighty patent family members on LANTHEUS MEDCL drugs in thirty-four countries and twelve supplementary protection certificates in eight countries.

Summary for Lantheus Medcl
International Patents:80
US Patents:5
Tradenames:9
Ingredients:8
NDAs:9

Drugs and US Patents for Lantheus Medcl

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lantheus Medcl GALLIUM CITRATE GA 67 gallium citrate ga-67 INJECTABLE;INJECTION 017478-001 Approved Prior to Jan 1, 1982 BS RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Lantheus Medcl DEFINITY perflutren INJECTABLE;INTRAVENOUS 021064-001 Jul 31, 2001 RX Yes Yes 8,658,205 ➤ Try a Free Trial Y ➤ Try a Free Trial
Lantheus Medcl XENON XE 133 xenon xe-133 GAS;INHALATION 017284-001 Approved Prior to Jan 1, 1982 RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Lantheus Medcl ABLAVAR gadofosveset trisodium SOLUTION;INTRAVENOUS 021711-002 Dec 22, 2008 DISCN No No 6,676,929 ➤ Try a Free Trial Y ➤ Try a Free Trial
Lantheus Medcl DEFINITY perflutren INJECTABLE;INTRAVENOUS 021064-001 Jul 31, 2001 RX Yes Yes 9,789,210 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Lantheus Medcl

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lantheus Medcl ABLAVAR gadofosveset trisodium SOLUTION;INTRAVENOUS 021711-001 Dec 22, 2008 5,362,475 ➤ Try a Free Trial
Lantheus Medcl ABLAVAR gadofosveset trisodium SOLUTION;INTRAVENOUS 021711-001 Dec 22, 2008 7,011,815 ➤ Try a Free Trial
Lantheus Medcl ABLAVAR gadofosveset trisodium SOLUTION;INTRAVENOUS 021711-001 Dec 22, 2008 8,394,356 ➤ Try a Free Trial
Lantheus Medcl MIRALUMA technetium tc-99m sestamibi kit INJECTABLE;INJECTION 019785-003 May 23, 1997 5,324,824 ➤ Try a Free Trial
Lantheus Medcl DEFINITY perflutren INJECTABLE;INTRAVENOUS 021064-001 Jul 31, 2001 6,033,645 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for Lantheus Medcl Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0253 Netherlands ➤ Try a Free Trial 300253, 20160116, EXPIRES: 20201002
0736 Netherlands ➤ Try a Free Trial PRODUCT NAME: TILMANOCEPT, DESGEWENST GELABELD MET TECHNETIUM TC 99M; REGISTRATION NO/DATE: EU/1/14/955 20141119
C/GB07/031 United Kingdom ➤ Try a Free Trial PRODUCT NAME: PERFLUTREN-CONTAINING LIPID MICROSPHERES; REGISTERED: UK EU/1/06/361/001 20060920
0806968/01 Switzerland ➤ Try a Free Trial FORMER REPRESENTANTIVE: BOVARD AG PATENTANWAELTE, CH
C/GB07/011 United Kingdom ➤ Try a Free Trial PRODUCT NAME: GADOFOSVESET TRISODIUM; REGISTERED: UK EU/1/05/313/001 20051003; UK EU/1/05/313/002 20051003; UK EU/1/05/313/003 20051003; UK EU/1/05/313/004 20051003; UK EU/1/05/313/005 20051003; UK EU/1/05/313/006 20051003; UK EU/1/05/313/007 20051003; UK EU/1/05/313/008 20051003; UK EU/1/05/313/009 20051003
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
US Department of Justice
Julphar
Chinese Patent Office
Mallinckrodt
Farmers Insurance
Fuji
Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.